• Je něco špatně v tomto záznamu ?

Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer

J. Sana, S. Hankeova, M. Svoboda, I. Kiss, R. Vyzula, O. Slaby

. 2012 ; 82 (2) : 114-118. [pub] 20120211

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12024032

Grantová podpora
NS10352 MZ0 CEP - Centrální evidence projektů
NS9814 MZ0 CEP - Centrální evidence projektů

OBJECTIVES: The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. METHODS: In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. RESULTS: Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. CONCLUSION: Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024032
003      
CZ-PrNML
005      
20141215125441.0
007      
ta
008      
120815e20120211sz f 000 0#eng||
009      
AR
024    7_
$a 10.1159/000336479 $2 doi
035    __
$a (PubMed)22328099
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sana, J. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
245    10
$a Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer / $c J. Sana, S. Hankeova, M. Svoboda, I. Kiss, R. Vyzula, O. Slaby
520    9_
$a OBJECTIVES: The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. METHODS: In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. RESULTS: Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. CONCLUSION: Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a kolorektální nádory $x genetika $x mortalita $x patologie $7 D015179
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nekódující RNA $x analýza $7 D022661
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a nádorové biomarkery $x analýza $7 D014408
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hankeova, S. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Svoboda, M. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Kiss, I. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Vyzula, R. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Slaby, O. $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
773    0_
$w MED00003601 $t Oncology $x 1423-0232 $g Roč. 82, č. 2 (20120211), s. 114-118
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22328099 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120815 $b ABA008
991    __
$a 20141215125540 $b ABA008
999    __
$a ok $b bmc $g 946180 $s 781360
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 82 $c 2 $d 114-118 $e 20120211 $i 1423-0232 $m Oncology $n Oncology $x MED00003601
GRA    __
$a NS10352 $p MZ0
GRA    __
$a NS9814 $p MZ0
LZP    __
$a Pubmed-20120815/12/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...